Mylan (MYL) Says EpiPen Pretax Profits Are 60% Higher Than it Told Congrees - DJ
- Wall Street gains, helped by oil, economic data
- Twitter (TWTR) 'Takeover Money' Moves On as 'Trump Money' Moves In
- Buy Any Seasonal Market Weakness Ahead of Year End Rally - Oppenheimer (SPY)
- Unusual 11 Mid-Day Movers 12/5: (NVCN) (BCEI) (MEMP) Higher; (GTXI) (CERC) (HDSN) Lower
- Oil hits 16-month high in buying rush after OPEC agreement
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Mylan (NASDAQ: MYL) Says EpiPen Pretax Profits Are 60% Higher Than it Told Congrees - DJ
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Spherix (SPEX) Announces Filing of New Patent Suit vs. Nortel Networks
- Novartis (NVS) Announces New Data from Tasigna ENESTop TFR Study; Rates Seen Consistent in Ph+ CML Patients
- Alnylam Pharma (ALNY) Announces Presentation of Updated Results from Phase 1/2 Study of ALN-CC5
Create E-mail Alert Related CategoriesCorporate News, Litigation, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!